Displaying 10 out of 4 results

  1. New Content Item

    Unequal HIV prevention pill use puts minority men at higher risk

  2. New Content Item

    FDA panel backs Gilead's HIV prevention drug for certain population

  3. A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California

    Patient groups push back against Gilead's pricey HIV prevention treatment

    Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker ...
  4. New Content Item

    HIV prevention pill recommended for healthy people at risk